A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-α maintenance therapy or observation, in small cell lung carcinoma patients with complete responses

✍ Scribed by Diego Tummarello; Davide Mari; Francesco Graziano; Pierpaolo Isidori; Gianluigi Cetto; Felice Pasini; Antonio Santo; Riccardo Cellerino

• Publisher: John Wiley and Sons
• Year: 1997
• Tongue: English
• Weight: 109 KB
• Volume: 80
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/(sici)1097-0142(19971215)80:12<2222::aid-cncr2>3.0.co;2-w

✦ Synopsis

BACKGROUND. Studies of chemotherapy for